Dear Health Care Professionals, NCCN has encountered unique issues related to caring for cancer patients in the current COVID-19 pandemic and has realized that their current standard-of-care NCCN Guidelines, do not adequately address some of these issues, such as the limited blood supply, possible impact on those with active infection, and measures that might shorten or prevent hospitalization. These issues may wax and wane, and may require continuous communication with local Blood Bank directors to optimize treatment.
Contributing institutions for this Short-Term Recommendations Specific to Issues with COVID-19 (SARS-CoV-2):
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Dana Farber/Brigham and Women’s Cancer Institute | Massachusetts General Hospital Cancer Center, Fox Chase Cancer Center, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Mayo Clinic Cancer Center, Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Roswell Park Comprehensive Cancer Center, O’Neal Comprehensive Cancer Center at UAB, University of Michigan Rogel Cancer Center, Fred & Pamela Buffet Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, UC San Diego Moores Cancer Center, Vanderbilt-Ingram Cancer Center, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and Yale Cancer Center/Smilow Cancer Hospital.
Regards
Dr Sina Ebrahimi
Pharm D.
Medical Advisor
Pooyesh Darou Biopharmaceutical Company
Download PDF